Amato MP - Search Results

1

Family planning considerations in people with multiple sclerosis.

Krysko KM, Dobson R, Alroughani R, Amato MP, Bove R, Ciplea AI, Fragoso Y, Houtchens M, Jokubaitis VG, Magyari M, Abdelnasser A, Padma V, Thiel S, Tintore M, Vukusic S, Hellwig K. Krysko KM, et al. Among authors: amato mp. Lancet Neurol. 2023 Apr;22(4):350-366. doi: 10.1016/S1474-4422(22)00426-4. Lancet Neurol. 2023. PMID: 36931808 Review.

2

Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis.

Amato MP, Fratiglioni L, Groppi C, Siracusa G, Amaducci L. Amato MP, et al. Arch Neurol. 1988 Jul;45(7):746-8. doi: 10.1001/archneur.1988.00520310052017. Arch Neurol. 1988. PMID: 3390030

3

Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up.

Amato MP, Ponziani G, Pracucci G, Bracco L, Siracusa G, Amaducci L. Amato MP, et al. Arch Neurol. 1995 Feb;52(2):168-72. doi: 10.1001/archneur.1995.00540260072019. Arch Neurol. 1995. PMID: 7848126

4

Long-term safety of azathioprine therapy in multiple sclerosis.

Amato MP, Pracucci G, Ponziani G, Siracusa G, Fratiglioni L, Amaducci L. Amato MP, et al. Neurology. 1993 Apr;43(4):831-3. doi: 10.1212/wnl.43.4.831. Neurology. 1993. PMID: 8469348

5

A prospective study on the prognosis of multiple sclerosis.

Amato MP, Ponziani G. Amato MP, et al. Neurol Sci. 2000;21(4 Suppl 2):S831-8. doi: 10.1007/s100720070021. Neurol Sci. 2000. PMID: 11205358

6

Safety and tolerability of cyclophosphamide 'pulses' in multiple sclerosis: a prospective study in a clinical cohort.

Portaccio E, Zipoli V, Siracusa G, Piacentini S, Sorbi S, Amato MP. Portaccio E, et al. Among authors: amato mp. Mult Scler. 2003 Oct;9(5):446-50. doi: 10.1191/1352458503ms926oa. Mult Scler. 2003. PMID: 14582767 Clinical Trial.

7

The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study.

Solaro C, Brichetto G, Amato MP, Cocco E, Colombo B, D'Aleo G, Gasperini C, Ghezzi A, Martinelli V, Milanese C, Patti F, Trojano M, Verdun E, Mancardi GL; PaIMS Study Group. Solaro C, et al. Among authors: amato mp. Neurology. 2004 Sep 14;63(5):919-21. doi: 10.1212/01.wnl.0000137047.85868.d6. Neurology. 2004. PMID: 15365151

8

Response to interferon-beta therapy in relapsing-remitting multiple sclerosis: a comparison of different clinical criteria.

Portaccio E, Zipoli V, Siracusa G, Sorbi S, Amato MP. Portaccio E, et al. Among authors: amato mp. Mult Scler. 2006 Jun;12(3):281-6. doi: 10.1191/135248506ms1278oa. Mult Scler. 2006. PMID: 16764340

9

Long-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosis.

Portaccio E, Zipoli V, Siracusa G, Sorbi S, Amato MP. Portaccio E, et al. Among authors: amato mp. Eur Neurol. 2008;59(3-4):131-5. doi: 10.1159/000111875. Epub 2007 Nov 30. Eur Neurol. 2008. PMID: 18057899 Clinical Trial.

10

Switching to second-line therapies in interferon-beta-treated relapsing-remitting multiple sclerosis patients.

Portaccio E, Zipoli V, Siracusa G, Sorbi S, Amato MP. Portaccio E, et al. Among authors: amato mp. Eur Neurol. 2009;61(3):177-82. doi: 10.1159/000189271. Epub 2009 Jan 8. Eur Neurol. 2009. PMID: 19129705

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

417 results

Search Page